GSA Capital Partners LLP Takes Position in Alignment Healthcare, Inc. $ALHC

GSA Capital Partners LLP purchased a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 86,412 shares of the company’s stock, valued at approximately $2,057,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in Alignment Healthcare by 10.9% in the fourth quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock valued at $305,983,000 after acquiring an additional 1,524,218 shares during the period. Wellington Management Group LLP grew its stake in shares of Alignment Healthcare by 26.9% during the 4th quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock worth $277,900,000 after purchasing an additional 2,981,166 shares during the period. T. Rowe Price Investment Management Inc. grew its stake in shares of Alignment Healthcare by 0.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after purchasing an additional 79,268 shares during the period. Invesco Ltd. increased its holdings in shares of Alignment Healthcare by 38.9% in the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after purchasing an additional 1,735,962 shares in the last quarter. Finally, 8 Knots Management LLC increased its holdings in shares of Alignment Healthcare by 6.4% in the 2nd quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock valued at $70,222,000 after purchasing an additional 300,409 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on ALHC. JPMorgan Chase & Co. reduced their price objective on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, August 4th. TD Cowen reaffirmed a “buy” rating on shares of Alignment Healthcare in a report on Monday, August 3rd. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. UBS Group reiterated a “neutral” rating on shares of Alignment Healthcare in a research report on Wednesday, July 8th. Finally, Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Seven equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $23.60.

Alignment Healthcare Trading Up 3.7%

Shares of ALHC stock opened at $13.96 on Friday. The stock has a market cap of $2.90 billion, a P/E ratio of 73.48 and a beta of 1.10. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 1.22. Alignment Healthcare, Inc. has a fifty-two week low of $13.05 and a fifty-two week high of $25.12. The business has a fifty day simple moving average of $19.43 and a 200-day simple moving average of $19.15.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. The business had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The business’s revenue for the quarter was up 31.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.07 EPS. On average, analysts forecast that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current fiscal year.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, insider Hyong Kim sold 35,951 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $19.86, for a total value of $713,986.86. Following the sale, the insider owned 331,750 shares of the company’s stock, valued at $6,588,555. This represents a 9.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Mark D. Kent purchased 14,848 shares of the stock in a transaction dated Tuesday, June 2nd. The stock was acquired at an average price of $13.31 per share, for a total transaction of $197,626.88. Following the completion of the transaction, the insider directly owned 14,848 shares of the company’s stock, valued at approximately $197,626.88. The trade was a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold a total of 1,009,951 shares of company stock valued at $18,597,287 in the last quarter. 5.20% of the stock is owned by corporate insiders.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.